NewsRoom Articles - Page 1401 of 1437

ThursdayDec 01, 2016 4:24 pm

Citius Pharmaceuticals, Inc. (CTXR) is “One to Watch”

Citius Pharmaceuticals, Inc. (OTCQB: CTXR), a specialty biopharmaceutical company that develops and commercializes therapeutics products, has been a topic of conversation among analysts since the initiation of its phase III clinical trial of Mino-Lok™, an antibiotic lock solution used to salvage infected central venous catheters and treat bloodstream infections that stem from catheters. This phase III randomized, double-blind, multi-center study involves 700 patients and has a primary goal of measuring whether or not the majority of subjects have overall success maintaining the treated central venous catheters during the cure test in week eight. The company will also be testing the…

ThursdayDec 01, 2016 3:10 pm

Agora Holdings, Inc. (AGHI) – Framing the Narrative for Social Brands

The human imagination is capable of incredibly brilliant creations, including the technological innovations that Agora Holdings, Inc. (OTC: AGHI) is developing to create tools that can help people and companies save time and improve performance, all while publishing more content. Agora Holdings, together with subsidiary Geegle Media and its affiliates, is a global family entertainment and media enterprise with five business segments: consumer products, interactive media, media networks, studio entertainment and television. Agora Holdings engages in the development of bespoke software applications from its base in North York, Canada. Agora and its subsidiary Geegle Media are committed to delivering media…

ThursdayDec 01, 2016 2:06 pm

Zogenix, Inc. (ZGNX) Develops Orphan Drug for Dravet Syndrome Epilepsy

Zogenix, Inc (NASDAQ: ZGNX) is a clinical stage pharmaceutical company committed to the development and commercialization of therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases. The company’s lead product candidate, ZX008, is currently being evaluated for the treatment of one such disease – Dravet Syndrome. Despite the name, orphan diseases affect adults as well. The soubriquet ‘orphan disease’ arose because pharmaceutical companies showed no interest in ‘adopting’ them due to their comparatively small market size. However, the Orphan Drug Act (ODA) of 1983 created financial incentives for drug and biologics manufacturers…

ThursdayDec 01, 2016 12:20 pm

Matinas BioPharma Holdings, Inc. (MTNB) is “One to Watch”

Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), is a biopharmaceutical company still in its clinical stages, focused on identifying and developing treatments for fungal and bacterial infections. Founded in 2012, the company’s goal is to change the way in which potent medicines are delivered and administered, with the aim of giving both physicians and patients better, safer, and more effective solutions to fight these infections. MTNB is working toward unique benefits through its lead drug candidates, MAT2501 and MAT2203. These benefits include oral administration and bioavailability, multi-organ protection, and targeted delivery directly to the infected areas. MAT2501 is used to treat…

ThursdayDec 01, 2016 10:19 am

Monaker Group, Inc. (MKGI) and Recruiter.com Announce Launch of Custom Travel Rewards Club

Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced the launch of a new travel service and loyalty program as part of its ongoing partnership with Recruiter.com, a leading global recruiting service and job market technology platform. According to the news release, the new travel program, which will be available to qualified Recruiter.com members at no additional cost, is designed to give these individuals access to a variety of special member benefits, including discounted travel and vacation packages offering a “best price” promise, customizable options to build trips with friends and associates, complimentary flight insurance, access to fast pass…

ThursdayDec 01, 2016 9:19 am

Dynagas LNG Partners LP (DLNG) is “One to Watch”

According to a past article on MarketWatch (http://nnw.fm/X7nYr), after the Fukushima nuclear disaster there was an increase in liquefied natural gas (LNG) demand in 2012. This meant that the LNG carrier fleet was operating at a 98% utilization rate. These numbers eventually decreased due to the delay of several liquefaction projects and slowing LNG demand in Asia, but things have since been looking up. Australia and North America will see the addition of significant liquefaction capacity over the next few years. According to the original article, this is expected to increase spending on LNG carriers for supply transportation, with a…

WednesdayNov 30, 2016 3:56 pm

Monaker Group, Inc. (MKGI) Building Innovative Travel Products for Work and Play

For six decades, Monaker Group (OTCQB: MKGI) has catered to leisure travelers seeking to book “vacations of a lifetime” or find “travel made easy” options. Along the way, the company has gained the knowledge and experience to be considered an industry-leading, technology-driven travel company. Now, equipped with decades of experience and leveraging over 60 years of operation in leisure travel, Monaker is expanding its reach to business travel, using the full resources of its multiple brands and divisions to offer novel travel products to executives and professionals traveling for work. Over the years, management has combined vital partnerships and established…

WednesdayNov 30, 2016 3:15 pm

eXp World Holdings, Inc. (EXPI) Welcomes Marsee Wilhems Team to eXp Realty

Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced that the Tucson-based Marsee Wilhems Team, one of the premier real estate teams in the country, has joined the Agent-Owned Cloud Brokerage®. The addition continues on eXp Realty’s recent trend of attracting top real estate professionals from across the country to its ranks. Within the last six weeks alone, the company has welcomed the Brent Gove Team, one of the top real estate teams in California; Darren James Real Estate Experts, which was ranked 51st in the nation by The Wall Street Journal in 2015; and the Eric Burch Real Estate…

WednesdayNov 30, 2016 1:08 pm

Recro Pharma, Inc. (REPH) Says No to Opioids for Post-Operative Pain Control with IV Meloxicam

An announcement earlier this week from revenue-generating specialty pharmaceutical company Recro Pharma, Inc. (NASDAQ: REPH) is good news for those suffering from pain after major surgery. From its headquarters in Malvern, Pennsylvania, the company announced positive results from a phase III clinical trial evaluating intravenous (IV) Meloxicam for the treatment of acute post-operative pain. In this trial, the second of two phase III trials, IV Meloxicam achieved the primary endpoint of a statistically significant differential in Summed Pain Intensity Difference over the first 24 hours (SPID-24) in patients who had undergone abdominoplasty surgery, as compared to placebo. With the positive…

WednesdayNov 30, 2016 11:32 am

GCard from GainClients, Inc. (GCLT) Helps Real Estate Professionals Connect with Customers

As the entire real estate industry is changing fast, with the advent of technology and enhanced interconnectivity set to significantly alter the sector’s business customs, GainClients, Inc. (OTC: GCLT) is staying ahead of the curve with its GCard networking system (http://nnw.fm/R5Pkp), which is designed to help real estate professionals better connect and communicate with their customers. With a growing number of real estate customers opting for online and mobile real estate solutions, GCard is a progressive integrated networking system that allows real estate brokers and agents to provide their customers with a wealth of information, including property details, lending requirements,…